The University of California supports early-stage investigators with pilot awards for innovative basic and translational HIV research through the 2026 Discovery program.
Funder: University of California
Due Dates (Anticipated): May 2027 (LOI) | July 2027 (Full application)
Funding Amounts: Up to $200,000 in direct costs over 2 years (plus up to 40% indirect costs); 10–20 pilot awards per cycle anticipated.
Summary: Supports early-stage investigators in California to conduct innovative basic or translational HIV research pilot studies to generate proof-of-concept data.
Key Information: This is a forecasted annual opportunity; all dates are projected and subject to change.
This annual funding opportunity from the University of California’s California HIV/AIDS Research Program (CHRP) is designed to support early-stage investigators (ESIs) in California who are pursuing pilot studies in basic biomedical or translational HIV research. The program aims to foster the next generation of HIV researchers by providing resources for proof-of-concept or feasibility studies that can serve as a platform for future, larger-scale funding. Projects should advance understanding of HIV prevention, treatment, or cure, and promote laboratory discoveries toward clinical or public health application. The initiative is highly competitive, with a focus on innovation and high-risk/high-reward research that may not be supported by other funders.